Home / Resource Library / An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

Results of a study investigating valemetostat for treatment of relapsed adult t-cell lymphoma.